Pharmacological therapies for cataract and refractive errors: landscaping niches of ocular drug patenting.

about

Topical composition for treating diabetic cataracts: a patent evaluation (WO2015026380A1).Towards the ophthalmology patentome: a comprehensive patent database of ocular drugs and biomarkers.

P2860

Q38896549-9F2FB1C4-55FF-453D-B32A-5B286F26958C Q47949621-4C3758FA-008F-4040-B7CA-16CE64D38318

P2860

Pharmacological therapies for cataract and refractive errors: landscaping niches of ocular drug patenting.

Item

http://www.wikidata.org/entity/Q38162916

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Pharmacological therapies for ...... ches of ocular drug patenting.

@en

type

Item

label

Pharmacological therapies for ...... ches of ocular drug patenting.

@en

prefLabel

Pharmacological therapies for ...... ches of ocular drug patenting.

@en

P1476

Pharmacological therapies for ...... ches of ocular drug patenting.

@en

P2093

Eva Mucke

http://www.w3.org/2001/XMLSchema#string

Hermann Am Mucke

http://www.w3.org/2001/XMLSchema#string

Peter Mucke

http://www.w3.org/2001/XMLSchema#string

P2860

The effect of an aldose reductase inhibitor on the galactose-exposed rabbit lens

Riboflavin/UVA collagen cross-linking-induced changes in normal and keratoconus corneal stroma

Comparison of the incidence and visual significance of posterior capsule opacification between multifocal spherical, monofocal spherical, and monofocal aspheric intraocular lenses.

Incidence of Nd:YAG capsulotomy after implantation of AcrySof multifocal and monofocal intraocular lenses: a case controlled study.

Clinical findings and treatments of granular corneal dystrophy type 2 (avellino corneal dystrophy): a review of the literature.

Ditopic complexation of selenite anions or calcium cations by pirenoxine: an implication for anti-cataractogenesis.

One million cataract surgeries: Swedish National Cataract Register 1992-2009.

Cataract-associated mutant E107A of human gammaD-crystallin shows increased attraction to alpha-crystallin and enhanced light scattering.

Vitamin C mediates chemical aging of lens crystallins by the Maillard reaction in a humanized mouse model.

P304

165-175

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4155/PPA.12.23

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258632160

http://www.w3.org/2001/XMLSchema#string

P698

24236781

http://www.w3.org/2001/XMLSchema#string

P921

patent

Pharmacological therapies for cataract and refractive errors: landscaping niches of ocular drug patenting.

about

P2860

P2860

Pharmacological therapies for cataract and refractive errors: landscaping niches of ocular drug patenting.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921